Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FXOther monoclonal antibodies and antibody drug conjugates
- Chemical substanceL01FX04Ipilimumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 3 registrations
- Yervoy 5 MG/ML Concentrado Para Solucion Para Perfusion53,5 mg · concentrado para solución para perfusión · Bristol-Myers Squibb Pharma Eeig
- Yervoy 5 MG/ML Concentrado Para Solucion Para Perfusion213 mg · concentrado para solución para perfusión · Bristol-Myers Squibb Pharma Eeig
- Yervoy 5 MG/ML Concentrado Para Solucion Para Perfusion50 mg · concentrado para solución para perfusión · Bristol-Myers Squibb Pharma Eeig
New Zealand
PHARMAC (NZ funding schedule) · 2 registrations
At a glance
- ATC code
- L01FX04
- Registers
- 10
- Historical lists
- 2
- Registrations
- 19
- With their own page
- 15
- Companies
- 9
All medicines with Ipilimumab
Human medicines from every register that match Ipilimumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
19 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Yervoy | United States | 3MG | injectable | Marketed | Bristol Myers Squibb |
| Yervoy | United States | 200MG/40ML | Injection | Marketed | Bristol-Myers Squibb Company |
| Yervoy | European Union | Authorised | Bristol-Myers Squibb Pharma EEIG | ||
| Yervoy 5 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 213 mg | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Yervoy 5 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 53,5 mg | concentrado para solución para perfusión | Marketed | Bristol-Myers Squibb Pharma Eeig |
| Yervoy 5mg/ml, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| Yervoy 5 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 50 mg | concentrado para solución para perfusión | Authorised | Bristol-Myers Squibb Pharma Eeig |
| Yervoy | Canada | 5 MG / ML | Solution | Marketed | Bristol-Myers Squibb Canada |
| Yervoy Injection Concentrate 5MG/ML | Singapore | 5mg/ml | injection, solution, concentrate | Authorised | Bristol-Myers Squibb (Singapore) Pte. LTD. |
| Yervoy | Brazil | Authorised | Bristol-Myers Squibb Farmacêutica Ltda | ||
| Yervoy® | Serbia | 5mg/mL | koncentrat za rastvor za infuziju | Authorised | Amicus SRB D.O.O. |
| Yervoy® | Serbia | 5mg/mL | koncentrat za rastvor za infuziju | Authorised | Amicus SRB D.O.O. |
| Yervoy | Croatia | Marketed | |||
| Yervoy | New Zealand | Inj 5 mg per ml, 10 ml vial | Funded | ||
| Yervoy | New Zealand | Inj 5 mg per ml, 40 ml vial | Funded | ||
| YERVOY 5 mg/ml intravenous infusion | Saudi Arabia | Authorised | Baxter Pharmaceutical Solution LLC | ||
| YERVOY 5 mg/ml intravenous infusion | Saudi Arabia | Authorised | Baxter Pharmaceutical Solution LLC | ||
| YERVOY 5 mg/ml | Romania | 5 mg/ml | conc. pt. sol. perf. | Status unknown | Bristol - Meyers Squibb Eeig |
| YERVOY 5 mg/ml | Romania | 5 mg/ml | conc. pt. sol. perf. | Status unknown | Bristol- Myers Squibb Pharma Eeig |
